Press-release for stocks

Prices are updated after-hours

crawled date : 2021 - 11 - 09

save search

Fullerton Ford Orange County Honors Veterans/Active Military During November with $5 Oil Change
Published: 2021-11-09 (Crawled : 20:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130

Communications

| Email alert Add to watchlist
ford

The Worldwide Optical Coatings Industry is Expected to Reach $19 Billion by 2026
Published: 2021-11-09 (Crawled : 20:00) - prnewswire.com
MTRN 4 | $119.95 2.03% 0.0% 100K

Non-Energy Minerals

| 29.66% | O: -0.55% H: 0.85% C: -1.02%
DOV | $172.29 1.18% 0.0% 770K

Producer Manufacturing

| -0.65% | O: 1.14% H: 0.72% C: -0.36%
optical

Impel NeuroPharma to Present at the Guggenheim Securities 3rd Annual Neuro/Immunology Conference
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
IMPL 4 | $0.2411 -77.19% 860K

Professional, Scientific, and T...

| -96.33% | O: -0.44% H: 0.0% C: 0.0%
immunology conference

Mereo BioPharma to Present at Two Upcoming Investor Conferences
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
RARE F | $45.06 3.14% 3.04% 840K

Health Technology

| -45.39% | O: -0.21% H: 0.0% C: 0.0%
MREO | $2.79 0.0% 790K

Health Technology

| 12.55% | O: -1.42% H: 0.0% C: 0.0%
biopharma conference

Tempest to Present at Two Upcoming Investor Conferences in November
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
TPST | $3.425 5.71% 5.4% 400K

Manufacturing

| -71.85% | O: 0.99% H: 0.0% C: 0.0%
pest conference

Rain Therapeutics Plans Phase 2 Merkel Cell Carcinoma Clinical Trial (MANTRA-3) of Milademetan
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
RAIN | $1.21 0.0% 3.7M

Manufacturing

| -92.67% | O: 0.36% H: 0.0% C: 0.0%
phase 2 trial cell carcinoma

Athenex Announces Exclusive License Agreement with National Cancer Institute to Utilize T Cell Receptors Targeting Mutated p53, KRAS, and EGFR for the Development of Autologous and Allogeneic Cell Therapies
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M

Health Technology

| -91.54% | O: -1.25% H: 0.63% C: -5.91%
cancer license t-cell

Oklahoma’s Highest Court Overturns Landmark Opioid Verdict Against J&J
Published: 2021-11-09 (Crawled : 20:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -8.61% | O: -0.59% H: 0.0% C: 0.0%
opioid

Duke Energy Florida expands solar energy in Sunshine State with completion of Duette facility
Published: 2021-11-09 (Crawled : 19:00) - prnewswire.com
DUK | News | $98.2 0.08% 0.0% 2.1M

Utilities

| -3.69% | O: -0.67% H: 0.62% C: 0.34%
solar energy

Immutep Announces Publication of AIPAC, TACTI-002 and TACTI-003 Abstracts for SITC 2021 Annual Meeting & AIPAC Global Webcast Details
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
IMMP | $2.53 9.05% 8.3% 72K

Health Technology

| -47.16% | O: 5.26% H: 0.0% C: -25.6%

Immutep Reports Improved and Statistically Significant Survival Benefit for Three Key Patient Groups in Final Phase IIb AIPAC Study Results in Metastatic Breast Cancer
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
IMMP | $2.53 9.05% 8.3% 72K

Health Technology

| -47.16% | O: 5.26% H: 0.0% C: -25.6%
results cancer breast cancer metastatic breast cancer

Medtronic to announce financial results for its second quarter of fiscal year 2022
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
MDT | $81.29 0.89% 0.0% 5.2M

Health Technology

| -33.92% | O: 0.23% H: 0.0% C: 0.0%
financial results results

Aravive Announces Positive Preliminary Data from Phase 1b Trial Evaluating Batiraxcept (AVB-500) in Combination with Cabozantinib in Clear Cell Renal Cell Carcinoma to be Presented at 2021 Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
ARAV | $0.0401 4.74% 4M

Health Technology

| -98.86% | O: 1.47% H: 2.91% C: -2.42%
immunotherapy phase 1 renal positive therapy cancer phase 1b trial phase 2b cell carcinoma

Daré Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
DARE | $0.306 3.62% 3.5% 320K

Health Technology

| -82.14% | O: 0.0% H: 0.0% C: 0.0%
conference

Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and uveal melanoma (mUM) at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
IMCR | $57.32 2.69% 2.62% 300K

Manufacturing

| Email alert Add to watchlist
immunotherapy therapy cancer

Tampa General Hospital and Kindred Healthcare Announce CEO of New TGH Rehabilitation Hospital
Published: 2021-11-09 (Crawled : 19:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130

Communications

| Email alert Add to watchlist
ceo

Cyrano Therapeutics Announces the Appointment of John Kollins to its Board of Directors
Published: 2021-11-09 (Crawled : 19:00) - prnewswire.com
STSA | $1.1 -0.9% -0.91% 0

Health Technology

| -81.82% | O: 0.66% H: 0.16% C: -4.11%

Quinoa Butternut Orange Stuffing
Published: 2021-11-09 (Crawled : 19:00) - limoneira.com
LMNR 4 | $19.68 -0.15% -0.15% 33K

Process Industries

| 21.22% | O: 0.43% H: 0.49% C: -0.86%

Jasper Therapeutics Announces Research Collaboration with AVROBIO to Evaluate JSP191 as Conditioning Agent in Clinical Studies of Ex Vivo Lentiviral Gene Therapy
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
JSPR | $22.0 -2.31% -2.36% 78K

| 139.8% | O: -2.22% H: 0.0% C: 0.0%
AVRO | $1.205 0.42% 0.41% 54K

Health Technology

| -80.29% | O: -1.63% H: 0.5% C: -3.64%
gene therapy therapy collaboration research

I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
Published: 2021-11-09 (Crawled : 19:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -8.61% | O: -0.59% H: 0.0% C: 0.0%
pharma